AstraZeneca Cancer Drug Improves...

AstraZeneca's groundbreaking cancer drug significantly boosts stomach cancer survival rates,...

What is the difference...

Dementia vs Alzheimer’s: What’s the Difference? Dementia and Alzheimer’s disease are often used interchangeably—but...

Dark Chocolate Demand in...

Uncover the 45% rise in dark chocolate demand in India...
HomeVIDEOSEscitalopram for Agitation...

Escitalopram for Agitation in Alzheimer’s Disease (S-CitAD) Study Ad 3



Are you or someone you know experiencing
agitation associated with Alzheimer’s disease? We are conducting a new research study that aims to improve symptoms of
agitation in Alzheimer’s disease. You or someone you care for may be eligible
for this study.
We are looking for volunteers who have a diagnosis of Alzheimer’s
disease and are experiencing any of these symptoms of agitation:
•Feelings of irritability
•Restlessness
•Fidgeting and pacing

•Difficulty cooperating with others
•Frustration or anger
Participants must have a study partner who can participate in
the study with them. All participants will receive psychosocial
counseling and compensation for their time.
To learn more about this study, visit our website at
For more information, please contact us at:
Kaitlin Romm, MS, LAT, AT
Email: RommKE@EVMS.EDU
757.446.7406

source

Continue reading

AstraZeneca Cancer Drug Improves Stomach Cancer Survival

AstraZeneca's groundbreaking cancer drug significantly boosts stomach cancer survival rates, offering hope to patients. Discover the latest research and insights here!

What is the difference between Alzheimer’s and Dementia?

Dementia vs Alzheimer’s: What’s the Difference? Dementia and Alzheimer’s disease are often used interchangeably—but they don’t mean the same thing. Dementia is an umbrella term describing a decline in memory, thinking, language, judgment, or other cognitive abilities that interferes with everyday...